BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2783312)

  • 1. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease.
    Diamond TH; Stiel D; Lunzer M; McDowall D; Eckstein RP; Posen S
    Gastroenterology; 1989 Jan; 96(1):213-21. PubMed ID: 2783312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol reduces bone formation and may cause osteoporosis.
    Diamond T; Stiel D; Lunzer M; Wilkinson M; Posen S
    Am J Med; 1989 Mar; 86(3):282-8. PubMed ID: 2784031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
    Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
    Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease.
    Diamond T; Stiel D; Mason R; Lissner D; Bikle D; Wilson S; Posen S
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1234-9. PubMed ID: 2584358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteocalcin and bone alkaline phosphatase in the serum of women with liver disease.
    Steinberg KK; Bonkovsky HL; Caudill SP; Bernhardt RK; Hawkins M
    Ann Clin Lab Sci; 1991; 21(5):305-14. PubMed ID: 1952779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Decreased serum osteocalcin level in non-alcoholic and alcoholic chronic liver diseases].
    Szalay F; Lakatos P; Németh J; Abonyi M; Büki B; Tarján G; Holló I
    Orv Hetil; 1991 Jun; 132(24):1301-5. PubMed ID: 1857606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry.
    Charhon SA; Delmas PD; Malaval L; Chavassieux PM; Arlot M; Chapuy MC; Meunier PJ
    J Clin Endocrinol Metab; 1986 Oct; 63(4):892-7. PubMed ID: 3488998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis.
    Brown JP; Delmas PD; Arlot M; Meunier PJ
    J Clin Endocrinol Metab; 1987 May; 64(5):954-9. PubMed ID: 3494038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone involvement in primary hemochromatosis and alcoholic cirrhosis.
    Conte D; Caraceni MP; Duriez J; Mandelli C; Corghi E; Cesana M; Ortolani S; Bianchi PA
    Am J Gastroenterol; 1989 Oct; 84(10):1231-4. PubMed ID: 2801672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis.
    Brown JP; Delmas PD; Malaval L; Edouard C; Chapuy MC; Meunier PJ
    Lancet; 1984 May; 1(8386):1091-3. PubMed ID: 6144827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteocalcin and bone histology in osteoporosis].
    Stracke H; Schulz A; Weber U; Ullmann J; Schatz H
    Klin Wochenschr; 1987 Nov; 65(22):1095-100. PubMed ID: 3501036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis?
    Chen CC; Wang SS; Jeng FS; Lee SD
    J Gastroenterol Hepatol; 1996 May; 11(5):417-21. PubMed ID: 8743912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic osteodystrophy].
    Suzuki K; Arakawa Y; Chino S; Yagi K
    Nihon Rinsho; 1998 Jun; 56(6):1604-8. PubMed ID: 9648489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease.
    Long RG; Meinhard E; Skinner RK; Varghese Z; Wills MR; Sherlock S
    Gut; 1978 Feb; 19(2):85-90. PubMed ID: 305386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings.
    Demiaux B; Arlot ME; Chapuy MC; Meunier PJ; Delmas PD
    J Clin Endocrinol Metab; 1992 May; 74(5):1146-51. PubMed ID: 1569162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone disorders in cholestatic liver diseases.
    Isaia G; Di Stefano M; Roggia C; Ardissone P; Rosina F
    Forum (Genova); 1998; 8(1):28-38. PubMed ID: 9514992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteocalcin and bone morphometric parameters in adults without bone disease.
    Garcia-Carrasco M; Gruson M; de Vernejoul MC; Denne MA; Miravet L
    Calcif Tissue Int; 1988 Jan; 42(1):13-7. PubMed ID: 3129163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in serum bone GLA protein with age and sex.
    Epstein S; Poser J; McClintock R; Johnston CC; Bryce G; Hui S
    Lancet; 1984 Feb; 1(8372):307-10. PubMed ID: 6141381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of osteomalacia in chronic cholestatic liver disease.
    Stellon AJ; Webb A; Compston J; Williams R
    Bone; 1986; 7(3):181-5. PubMed ID: 3768195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.